Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Consumer Staples Select Sector SPDR Fund (XLP) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Consumer Staples Select Sector SPDR FundTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Consumer Staples Select Sector SPDR Fund vs DENTSPLY SIRONA Inc — how do they compare? Consumer Staples Select Sector SPDR Fund trades at $83.24 (market cap $13.50B), while DENTSPLY SIRONA Inc trades at $8.81 (market cap $1.73B). The key difference: Consumer Staples Select Sector SPDR Fund is far larger — about 7.8× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Consumer Staples Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Consumer Staples Select Sector SPDR Fund for 72 Days and DENTSPLY SIRONA Inc for 72 Days on average.

XLPXRAY
Market Cap
$13.50B$1.73B
Volume
14,599,9536,198,582
52-Week High
$90.00$14.68
52-Week Low
$75.61$8.52
Typical Hold Time
72 Days72 Days
Sector
—Health
Enterprise Value
—$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Consumer Staples Select Sector SPDR Fund

XLP (Consumer Staples Select Sector SPDR ETF) trades at $83.21, up 1.85% with bullish technical signals from moving averages and oscillators. The ETF has gained 6.6% year-to-date, outperforming consumer discretionary stocks. Analyst consensus is strongly positive with 100% buy ratings. Recent news highlights XLP's defensive characteristics amid economic uncertainty and its competitive expense ratio advantage over peers.

The outlook remains favorable given XLP's defensive positioning in consumer staples, though rising interest rates pose a headwind. Investment opportunity lies in the ETF's stability during market volatility, while risks include persistent inflation pressures and potential consumer spending slowdown. The technical setup suggests continued upward momentum with support at $82-83 levels.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

XLP
100% Buy0% Sell
Avg holding period · 72 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Consumer Staples Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.

Read more on XLP →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →